<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" type="text/css" href="css/style-manual.css">
    <link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
    <script src="js/script.js"></script>
</head>
<body>
    <!--Allertin-------------------------------------------------------->
    <div class="bodyDiv" id="idAllertin">
    <div class="w3-container w3-center w3-animate-left">
        <h2 class="mango">Allertin</h2>
    </div>

<div class="HL1"> Orientation & Presentation:</div>

<table class="table1">
	<tr><td>
<div class="HL">Brand Name:</div>
Allertin<br><br>
</tr></td>
	<tr><td>
<div class="HL">Generic & Strength:</div>
	Allertin 20 Tablet: Each tablet contains Bilastine INN 20 mg.<br>
	Allertin 10 ODT: Each tablet contains Bilastine INN 10 mg.<br>
	Allertin 60ml OS: 2.5mg/ ml<br><br>
	</tr></td>



	<tr><td>
<div class="HL">Dosage Form:</div>
    
	Tablet<br>
	ODT(Orally dissolving tablet)<br>
	Oral Solution<br><br>
</tr></td>



	<tr><td>
<div class="HL">Therapeutic Class:</div>
	
	Anti- histamine(2<sup>nd</sup> Generation)<br><br>
</tr></td>






	<tr><td>
<div class="HL">Sub Therapeutic class:</div>
	
	---
<br><br>
</tr></td>



	<tr><td>
<div class="HL">Commercial Pack:</div>
	 
	Allertin 20 Tablet: 3×10's<br>
	Allertin 10 ODT: 3×10's<br>
	Allertin Oral Solution: 60ml<br><br>
</tr></td>



	<tr><td>
<div class="HL">Price (TP):</div>
     
	Allertin 20 Tablet: 15 Taka<br>
	Allertin 10 ODT: 13 Taka<br>
    Allertin Oral Solution:  120 Taka<br><br>
</tr></td>




	<tr><td>
<div class="HL">Flavour:</div>
    .
	 
<br><br>
</tr></td>

	<tr><td>
<div class="HL">Indication:</div>
    
Allergic rhinitis(SAR and PAR),<br>
Chronic urticaria<br>	
<li>Seasonal Allergic Rhinitis:</li>
Bilastine is indicated for the symptomatic relief of nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR) in patients of 12 years of ege and older.
<li>Chronic Spontaneous Urticaria:</li>
Bilastine is indicated for the relief of the symptoms associated with chronic spontaneous urticaria (CSU) (e.g. pruritus and hives), in patients of 18 years of age and older.<br><br>
</tr></td>

	<tr><td>
<div class="HL">Pregnancy:</div>


There are no adequate and well-controlled studies on pregnant women. Until such data become available, Bilastine should be avoided during pregnancy, unless advised by a physician.<br><br>
</tr></td>
	<tr><td>
<div class="HL">Lactation:</div>


It is unknown whether Bilastine is excreted in human breast milk. A decision to continue/discontinue breastfeeding or to continuel discontinue therapy with Bilastine should be made taking the benefit of Bilastine therapy to the mother into account.<br><br>
</tr></td>






	<tr><td>
<div class="HL">Children:</div>
    
	Children from 2 years of age.<br><br>
</tr></td>




	<tr><td>
<div class="HL">Brand Name Justification:</div>
    <b>Aller</b>gy(Indication)+ Bilas<b>tin</b>e= Allertin<br><br>
</tr></td>

	<tr><td>
<div class="HL">Brand Slogan:</div>

Improves quality of life<br><br>
</tr></td>

	<tr><td>
<div class="HL">Dosage & Administration:</div>


&#x2022; For adults: 20 mg bilastine (1 tablet) once daily<br>
&#x2022; 2-11 years children: 4 ml once daily (Allertin OS)<br>
&#x2022; More than 12 years of age: 8 ml once daily (Allertin OS)<br><br>
</tr></td>

	<tr><td>
<div class="HL">Key Selling Points:</div>


&#x2022; Allertin does not cross blood-brain barrier. So it does not produce sedation.<br>
&#x2022; Does not hamper daily activities like office work & driving<br>
&#x2022; Offers successful control of allergic rhinitis<br>
&#x2022; Ensures quickest relief from chronic urticaria with improved quality of life<br><br>

&#x2022; Offers successful control of allergic rhinitis<br>
&#x2022; Doesn't hamper daily activities like office work & driving<br>
&#x2022; Ensures quickest relief from chronic urticaria with improved quality of life
</tr></td>

	<tr><td>
<div class="HL">Target Doctor:</div>


&#x2022; Child specialist<br>
&#x2022; Skin & VD <br>
&#x2022; Chest Sp.<br>
&#x2022; Eye Sp.<br>
&#x2022; ENT Sp.<br>
&#x2022; Medicine Sp.<br>
&#x2022; Gynaecologist<br>
&#x2022; GPs
<br><br>
</tr></td>



	<tr><td>
<div class="HL">Side effects:</div>


Common: Drowsiness, headache. Rare: Anxiety, Increased appetite, Asthenia, Diarrhoea, Dry mouth, Dyspnoea, Fever, Gastritis, Gastrointestinal discomfort, Insomnia etc.<br><br>
	</r></td>
</table>


<table class="table6">
<tr>
<td>
<b>Mechanisms of Action</b>
</td>
</tr>
<tr>
<th> 
Allertin
</th>
</tr>
<tr>
<td>
<b>&#8681;</b>
</td>
</tr>
<tr>
<td>
Selectively binds with histamine H<sub>1</sub> receptor
</td>
</tr>
<tr>
<td>
<b>&#8681;</b>
</td>
</tr>
<tr>
<td>
Prevents histamine release from mast cells
</td>
</tr>
<tr>
<td>
<b>&#8681;</b>
</td>
</tr>
<tr>
<td>
Reduces allergic symptoms
</td>
</tr>
</table>
<br><br>

<li><b>Mode of Action of ODT:</b></li>
<table class="table6">
<tr>
<td>
<b>Mechanisms of Action of ODT:</b>
</td>
</tr>
<tr>
<th> 
Orally disintegrating tablet contains fast dissolving granules and disintegrating agent
</th>
</tr>
<tr>
<td>
<b>&#8681;</b>
</td>
</tr>
<tr>
<td>
Fast dissolving granules dissolve & tablet gets disintegrated with the help of saliva
</td>
</tr>
<tr>
<td>
<b>&#8681;</b>
</td>
</tr>
<tr>
<td>
Active ingredient is absorbed through mucus membranes in the mouth and GIT
</td>
</tr>
<tr>
<td>
<b>&#8681;</b>
</td>
</tr>
<tr>
<td>
Finally gives fast antihistaminic activity
</td>
</tr>
</table>
<br><br>

<b>ODT shows more advantages than conventional tablet</b><br>
Clinical advantages:<br>
• Enhanced oral absorption<br>
• Faster onset of action<br>
• Minimized first pass effect<br>
• Increased bioavailability<br>
Patients Convenience:<br>
• Improved patients compliance<br> 
• Convenient where water is not available e.g. traveling<br>
• Ease of administration to patients having difficulty in swallowing<br>
Formulation advantages:<br>
• Rapid disintegration<br>
• Improved taste 
<br><br>

<li><b>Model detail Talk</b></li>
Always open with social talk<br>
Dear Sir/Madam:
In your daily practice you get a lot of child patients who are suffering from
allergic rhinitis as well as chronic urticaria and both have an effect on
quality of life of children which can lead to poor school performance.To
treat these conditions, you commonly prescribe anti-histamines. Am I right sir/madam?<br>

Detail the 2nd page:<br>
Dear Sir/Madam:
To ensure childrens' safety and sedation-free antihistamine therapy,
Navana Pharma introduces Allertin Oral Solution. Allertin Oral Solution
can be given to children from 2 years of age.<br>
FAB 1:<br>
Respected sir/madam:
Allertin Oral Solution is significantly more effective than fexofenadine in
reducing the Total Nasal Symptom Score (TNSS), especially in case of
reducing total nasal secretion.<br>
FAB 2:<br>
Sir/Madam:
Bilastine has a placebo like safety and tolerability profile and you can
prescribe Allertin OS confidently for the lovely babies.<br>
FAB 3:<br>
Respected sir/madam:
Allertin (Bilastine) shows fastest onset of action to reduce maxium wheal
and flare area & ensures quickest relief from chronic urticaria with
improved quality of life.<br>
Close call with sharing summary of benefits and commitment of Rx:<br>
Allertin OS is available at x, y, z pharmacy (tell pharmacy Sir/Madam: Considering all these benefits, may I expect 5 Rx for your next names). Navana Pharma also has Allertin 20 Tab. Thank you sir.
<br><br>


<div class="HL1">Frequently Asked Questions (FAQ):</div>
<div class="FQ">01. What is the brand name justification of Allertin?</div>
Ans: <b>Aller</b>gy (indication) + Bilas<b>tin</b>e = Allertin<br>
	
<div class="FQ">02. What is the half-life of Bilastine?</div>
Ans: Bilastine has a mean elimination half-life of approximately 12-14.5 hours.<br>
	
<div class="FQ">03. What is the price of Allertin OS?</div>
Ans: 120 taka (60 ml pack).<br>

<div class="FQ">04. From which age can Allertin OS be given to children?</div>
Ans: Allertin OS can be given to children from 2 years of age.<br>

<div class="FQ">05. What is the duration of treatment for Allertin?</div>
Ans: For seasonal allergic rhinitis, treatment can be discontinued after the symptoms have resolved and
reinitiated upon their reappearance. In perennial allergic rhinitis continued treatment may be proposed to
the patients during the allergen exposure periods. For urticaria the duration of treatment depends on the
type, duration and course of the complaints.<br>

<div class="FQ">06. Why should Allertin be taken 1 hour before or 2 hours after food intake?</div>
Ans: Food significantly reduces the oral bioavailability of Bilastine by 30%. Therefore, for better bioavailability and efficacy Allertin should be taken 1 hour before or 2 hours after food intake.<br>

<div class="FQ">07. What is Total Nasal Symptom Score (TNSS)?</div>
Ans: The Total Nasal Symptom Score (TNSS) is the sum of scores for each of nasal congestion, sneezing, nasal itching, and rhinorrhea at each time point, using a four point scale (0–3).<br>

<div class="FQ">8. What are the types of histamine receptor in our body?</div>
Ans: There are four types of Histamin receptor H1, H2, H3, and H4.<br>

<div class="FQ">9. What are the location of H1 receptor in our body?</div>
Ans: Histamine H1 receptors are expressed widely in the body, in particular in tissues such as smooth muscle, endothelial cells, adrenal medulla, heart, and central nervous system.
<br><br>

<li><b>Detail Talk</b></li>
... when a person takes sedative antihistamines to cure frequently occurring allergy related
symptoms. Bilastine is a novel, 2nd generation antihistamine which is a non-sedating, well-tolerated
H, receptor antagonist.<br> 
In clinical studies, Bilastine has shown to be effective in allergic rhinoconjunctivitis and chronic
urticaria. Moreover, Bilastine meets *EAACI/ARIA criteria for medications used in the treatment of
allergic rhinitis.<br> 
To ensure patients' safety and sedation-free antihistamine therapy,<br> 
NAVANA PHARMA<br> 
Introduces<br> 
Allertin 20<br> 
Bilastine INN 20 mg Tablet<br> 
<b> Improves quality of life</b><br> 

Confirms a non-sedating antihistamine<br>

Bilastine (20mg)<br>
Fexo fenadine (60mg)<br>
Levocetirizine (5mg)<br>
Ebastine (10mg)<br>
Loratadine (10mg)<br>
Cetirizine (10mg)<br>
Diphenhydramine (30mg)<br>
Ketotifen (1mg)<br><br>
<b>Does not hamper daily activities like office work & driving.</b><br><br>

<b>Significantly more effective than Fexofenadine in reducing the Total Nasal Symptom Score</b><br><br>

Bilastine<br>
37.1%<br><br>
Fexofenadine
13.5%<br><br>
Offers successful control of allergic rhinitis<br><br>

Fastest onset of action in chronic urticaria<br>
2 hrs-Bilastine<br>
9hrs-Desloratadine<br>
24hrs-Rupatadine<br>
Ensures quickest relief from chronic urticaria with improved quality of life<br><br>


KSP:<br>
&#8227; Does not hamper daily activities like office work & driving<br>
&#8227; Offers successful control of allergic rhinitis<br>
&#8227; Ensures quickest relief from chronic urticaria with improved quality of life<br><br>

<li><strong>Detailing of Allertin</strong></li>
<li>Allertin 20
Bilastine INN 20 mg Tablet<br>
Improves quality of life<br>
Dear Sir/Madam:<br>
In your daily practice you get a lot of patients who are suffering from
allergic rhinitis as well as chronic urticaria. To treat these conditions,
you commonly prescribe an anti-histamine. But in prefering an
anti-histamine, sedation might be a big problem.<br>
So, <b>Navana Pharma introduces </b><strong>Allertin</strong><br>
<li>Allertin does not cross blood-brain barrier. So it does not produce
sedation.</li>
<li>Does not hamper daily activities like office work & driving</li>
<li>Offers successful control of allergic rhinitis</li>
<li>Ensures quickest relief from chronic urticaria with improved quality of life</li>
Sir/Madam,<br>
Considering all these benefits, may I expect 3 Rx of Allertin per day?<br>
Thank you sir. Allertin is available at x, y, z Pharmacy.<br><br>


<b>Short Detailing:</b><br>
Dear Sir/Madam<br>
In your daily practice, you get a lots of patients who are suffering from allergic rhinoconjunctivitis as well as chronic urticaria. To treat these conditions you commonly prescribe anti-histamines.<br>
Navana Pharma offers "Allertin".<br>
• Offers successful control of allergic rhinitis<br>
• Doesn't hamper daily activities like office work & driving<br>
• Ensures quickest relief from chronic urticaria with improved quality of life<br>
Sir/Madam:<br>
Considering all these benefits, may I expect 5 Rx for your next available patients? Allertin is available at x, y, z Pharmacy. For your kind information we have also Allertin OS for children. Thank you sir.<br><br>


<li><strong>Prescribing Information:</strong></li>
<li>Composition: Allertin 20 Tablet: 
Each tablet contains Bilastine INN 20 mg. 

<li>Pharmacology: </li>
Bilastine is a non-sedating, long-acting histamine antagonist with selective
peripheral H1 receptor antagonist affinity and no affinity for muscarinic receptors. Bilastine inhibits histamine-induced wheal and flare skin reactions for 24 hours following single
dose.
<li>Indication: </li>
<li>Seasonal Allergic Rhinitis: </li>
Bilastine is indicated for the symptomatic relief of nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR) in patients of 12
years of ege and older. Chronic Spontaneous Urticaria: Bilastine is indicated for the relief of the symptoms associated with chronic spontaneous urticaria (CSU) (e.g. pruritus and
hives), in patients of 18 years of age and older. 

<li>Dosage & Administration: </li>
Adults and adolescents 12 years of age and above: a 20 mg tablet once daily. The tablet should be
taken one hour before or two hours after intake of food or as directed by the physician.

<li>Contraindication: </li>
Bilastine is contraindicated in patients with hypersensitivity to
Bilastine or to any ingredient in the formulation or component of the tablet.

<li>Warning & Precaution: </li>
Bilastine should be avoided in subjects with moderate or severe renal
impairment 

<li>Side Effects: </li>
Common: Drowsiness, headache. Rare: Anxiety, Increased appetite, Asthenia, Diarrhoea, Dry mouth, Dyspnoea, Fever, Gastritis, Gastrointestinal
discomfort, Insomnia etc.

<li>Use in Pregnancy & Lactation: </li>
There are no adequate and well-controlled studies on pregnant women. Until such data become available, Bilastine
should be avoided during pregnancy, unless advised by a physician. It is unknown whether Bilastine is excreted in human breast milk. A decision to continue/discontinue
breastfeeding or to continuel discontinue therapy with Bilastine should be made taking the benefit of Bilastine therapy to the mother into account.

<li>Use in Children & Adolescents: </li>
The safety and efficacy of Bilastine in children & adolescent have not been established. 

<li>Drug Interaction: </li>
Ketoconazole or Erythromycin: Concomitant
administration of Bilastine and Ketoconazole or Erythromycin increases Bilastine AUC 2-fold and Cmax 2-3-fold.

<li>Overdose: </li>
Information regarding acute overdose is limited.
After administration of Bilastine at doses 10 to 11 times the therapeutic dose (220 mg as single dose; or 200 mg/day for 7 days) to healthy volunteers, frequency of treatment
emergent adverse events are two times higher than with placebo. The adverse reactions most frequently reported are dizziness, headache and nausea. In the event of overdose,
symptomatic supportive treatment is recommended.
<li>Storage: </li>
Store below 30°C, protected from light & in a dry ple. Keep all medicines out of the reach of children.
<li>Packing:</li>
Allertin 20 Tablet: Each box contains 3X10 tablets in Alu-Alu blister pack and an insert<br><br>
</div>   
<footer>
    <p>© 2024 Md. Nurullah. All rights reserved.</p>
</footer>
<center><div class="ovalEnd">The End-Allertin</div></center><!--End Line---->
</body>
</html>